News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>UBS Mildly Raises TIGERMED's TP to HKD57.1; 3Q Rev. in Line
According to a report from UBS, TIGERMED (03347.HK)'s 3Q25 revenue rose by 3.9% YoY to RMB1.78 billion, in line with both the market's market and the broker's expectati...
Reset
Send
The window will close in 5 seconds
<Research>UBS Mildly Raises TIGERMED's TP to HKD57.1; 3Q Rev. in Line
Close
Recommend
7
Positive
3
Negative
7
 
SHORT SELL
 
STOCK INFO

According to a report from UBS, TIGERMED (03347.HK)  -0.040 (-0.086%)    Short selling $14.26M; Ratio 11.550%   's 3Q25 revenue rose by 3.9% YoY to RMB1.78 billion, in line with both the market's market and the broker's expectations.

The company's net profit attributable to shareholders surged by 98.7% to RMB637 million, way above the market's and the broker's expectations, thanks to the contribution of RMB557 million from changes in the fair value of financial assets and investment income. Its recurring profit and GPM, however, fell by 54.2% and 9.8 ppts YoY to RMB115 million and 27.5%, respectively.

UBS slightly raised its target price for TIGERMED from HKD56.3 to HKD57.1 and kept the Buy rating unchanged.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-10-31 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.